Treatment.com unveils Merlin - Enterprise Intelligence (AI) Platform for Healthcare

Treatment.com, a Minnesota-based healthcare AI solutions company, announced the first glimpse of its game-changing MerlinTM – Enterprise Intelligence AI Platform (EIP) solution, creating a new category of healthcare Artificial Intelligence (AI).According to John Fraser, serial tech entrepreneur, President and CEO, "This unique enterprise class intelligence platform brings forth an entirely new ethos to healthcare, more akin to Uber, Airbnb and Wikipedia, rather than traditional healthcare IT data models. Merlin's Multi-Modular Enterprise architecture is built by physicians and has the ability to manage limitless categories of data consumers, diagnostic clinicians and commercial users, such as payers, ACO's, clinical research organizations, pharma and the biotech world. Unlike other healthcare artificial intelligence companies, we target the point-of-care diagnosis and therefore can affect and impact all stakeholders in healthcare, globally."Merlin - Enterprise Intelligence Platform (EIP) creates an entire new category, due to the healthcare-wide reach of modules and applications. The multi-modular aspect truly provides value exchange to all consumers, clinicians and commercial users. Merlin has the innate ability to become a guiding force in the move towards value-based care. Providing financial, legal and clinical risk mitigation, the Holistic Healthcare Enterprise Intelligence Platform (EIP) targets improved patient safety, cost of care and overall healthcare outcomes, globally."After decades of searching for a Healthcare IT Unicorn, I believe Treatment delivers the requirements. This incredible horizontal platform sets forth a framework allowing for multiple business models to be built and supported. Treatment's physician-built platform serves the masses and the platform approach lays the foundation for many impactful tools to the market. Everything about Treatment is different, from the commercial platform ethos to the unique architecture, delivering a comprehensive set of Amazonian level possibilities," as stated by Dr Paul A. Markham, Chief Strategy Officer of Treatment.About Treatment.com Healthcare's Artificial Intelligence PlatformBased in Minneapolis, MN, Treatment's MerlinTM - Enterprise intelligence Platform (EIP) delivers a unique suite of modules serving the consumer, clinical and commercial stakeholders in healthcare.  Furthermore, the Merlin Platform brings forth superiority over conventional artificial intelligence solutions by delivering hybrid commercial pricing models, challenging traditional care models. The platform allows for information exchange, commercial value exchange and commercial software development.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.